Enhanced oxidative stress in hypertrophic cardiomyopathy

被引:0
|
作者
Paweł P. Dimitrow
Anetta Undas
Paweł Wołkow
Wiesława Tracz
Jacek S. Dubiel
机构
[1] Jagiellonian University,2nd Department of Cardiology, Collegium Medicum
[2] Collegium Medicum Jagiellonian University,Department of Cardiac and Vascular Disease
[3] Jagiellonian University,Department of Pharmacology, Collegium Medicum
来源
Pharmacological Reports | 2009年 / 61卷
关键词
hypertrophic cardiomyopathy; oxidative stress;
D O I
暂无
中图分类号
学科分类号
摘要
Elevated plasma levels of inflammation and endothelial dysfunction markers have been reported in patients with hypertrophic car diomyopathy (HCM). The aim of the current study was to determine whether HCM is associated with enhanced oxidative stress. We enrolled 54 HCM patients with sinus rhythm, including 21 subjects with a left ventricular outflow tract (LVOT) obstruction (gra dient > 30 mmHg), and 54 age- and sex-matched controls without cardiovascular diseases. Serum levels of 8-isoprostaglandin F2a (8-iso-PGF2α), a stable marker of oxidative stress, were determined.
引用
收藏
页码:491 / 495
页数:4
相关论文
共 50 条
  • [21] Safety of stress testing in patients with hypertrophic cardiomyopathy
    Drinko, JK
    Nash, PJ
    Lever, HM
    Asher, CR
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (11): : 1443 - 1444
  • [22] Stress-echocardiography in hypertrophic and dilated cardiomyopathy
    Duplyakov, D. V.
    KARDIOLOGIYA, 2007, 47 (07) : 68 - 71
  • [23] IMPACT OF HYPERTROPHIC CARDIOMYOPATHY ON IN-HOSPITAL OUTCOMES OF PATIENTS WITH STRESS CARDIOMYOPATHY
    Thwe, Ei Ei
    Modi, Vivek Amit
    Shah, Kashyap
    Ferraro, Bruce Francis, Jr.
    Desai, Spandan
    Shirani, Jamshid
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 465 - 465
  • [24] Stress Cardiomyopathy in a Patient with Hypertrophic Cardiomyopathy: Case Presentation and Review of the Literature
    Vinardell, Juan M.
    Mihos, Christos G.
    Nader, Adam
    Ro, Richard
    Escolar, Esteban
    Santana, Orlando
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2018, 19 (02) : 65 - 68
  • [25] Manganese-enhanced magnetic resonance imaging in dilated cardiomyopathy and hypertrophic cardiomyopathy
    Spath, N. B.
    Singh, T.
    Papanastasiou, G.
    Kershaw, L.
    Baker, A. H.
    Janiczek, R. L.
    Gulsin, G. S.
    Dweck, M. R.
    McCann, G.
    Newby, D. E.
    Semple, S., I
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2021, 22 (12) : 1463 - 1472
  • [26] HYPERTROPHIC APICAL CARDIOMYOPATHY - A SUBTYPE OF HYPERTROPHIC CARDIOMYOPATHY
    ABINADER, EG
    RAUCHFLEISCH, S
    NASCHITZ, J
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1982, 18 (10): : 1005 - 1009
  • [27] Iron and oxidative stress in cardiomyopathy in thalassemia
    Berdoukas, Vasilios
    Coates, Thomas D.
    Cabantchik, Zvi Ioav
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 88 : 3 - 9
  • [28] Role of Oxidative Stress in Diabetic Cardiomyopathy
    De Geest, Bart
    Mishra, Mudit
    ANTIOXIDANTS, 2022, 11 (04)
  • [29] Why LV dilatation with vasodilator stress in hypertrophic cardiomyopathy?
    Brunken, Richard C.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2016, 23 (06) : 1315 - 1318
  • [30] Why LV dilatation with vasodilator stress in hypertrophic cardiomyopathy?
    Richard C. Brunken
    Journal of Nuclear Cardiology, 2016, 23 : 1315 - 1318